Historical Fellowship

Biotechnology Regulatory Fellowship 2027: $70,000 Six-Month National Academies Fellowship in Washington, D.C.

Historical reference for the closed 2027 National Academies Biotechnology Regulatory Fellowship. The six-month program offered eligible U.S. citizens a $70,000 grant stipend for full-time seminars, horizon scanning, mentoring, and a paired capstone project.

FindMyMoney.App
Published by FindMyMoney.App
Official source: National Academies of Sciences, Engineering, and Medicine
đź’° Funding $70,000 grant stipend paid in monthly installments over six months
đź“… Deadline Historical reference
📍 Location United States and Washington, D.C.
🏛️ Source National Academies of Sciences, Engineering, and Medicine

Biotechnology Regulatory Fellowship 2027: $70,000 Six-Month National Academies Fellowship in Washington, D.C.

The National Academies of Sciences, Engineering, and Medicine’s 2027 Biotechnology Regulatory Fellowship application has closed. The official program page gives the application deadline as August 31, 2026 at 11:59 p.m. U.S. Eastern Time, and states that applications are under review. This page is a historical reference to that completed application cycle; it is not an open call. The National Academies has not announced a later cycle on the official program page, so no future deadline is listed here.

The 2027 fellowship itself is a six-month, full-time professional-development program in Washington, D.C. The published term begins February 1, 2027 and ends July 31, 2027. Each fellow receives a $70,000 stipend in the form of a grant, paid in monthly installments during the term to offset living expenses. Fellows are not eligible for National Academies employee benefit programs. The offer is therefore distinct from an employee salary and benefits package.

The fellowship is designed for early-career professionals interested in regulatory challenges presented by novel biotechnology products. Fellows participate in expert seminars, conduct horizon scanning for products that lack existing or consistent regulatory risk-assessment pathways, and develop capstone projects in pairs. This archive preserves the cycle’s verified dates, award, eligibility and application requirements so readers can understand what the program offered and recognize that this particular application window has ended.

Key details

DetailConfirmed information
OpportunityBiotechnology Regulatory Fellowship 2027 (closed cycle)
Funder and administratorCommittee on Science, Technology, and Law, National Academies of Sciences, Engineering, and Medicine
Award$70,000 grant stipend, paid monthly over six months
Programme dates1 February 2027 to 31 July 2027
LocationWashington, D.C.
Work patternFull time, 37.5 hours per week
Application deadlineAugust 31, 2026 at 11:59 p.m. U.S. Eastern Time; application closed
Eligibility coreU.S. citizenship, relevant advanced degree, three to five years of relevant professional experience
Application routeThe official Biotechnology Regulatory Fellowship application site; submissions are closed
Contact[email protected]

The dates and award terms above come from the National Academies’ official application-process page. That page now explicitly says that the application for 2027 fellowships has closed. It lists review during September and October 2026, status notifications in November 2026 and recipient announcements on December 1, 2026. It does not state a fixed number of fellowships, employee benefits, or a separate research budget. The $70,000 grant is intended to offset living expenses; the public terms do not promise that it will cover every cost of living in Washington, D.C.

What the fellowship offers

The programme is intended to build practical judgment about biotechnology regulation. Its description focuses on products that may emerge over the coming decades and may not fit existing agency rules or risk-assessment pathways. A fellow is therefore not simply reading about regulation. The fellowship asks participants to identify where current approaches may be incomplete, understand the scientific or technical features creating the problem, and help frame options that agencies could use.

The fellowship includes a series of seminars led by subject-matter experts. It also includes horizon-scanning activities: fellows look for biotechnology products that may lack an existing, consistent, or sufficiently clear regulatory route. This makes the opportunity relevant to applicants who enjoy structured uncertainty and evidence-based policy analysis. It is less suitable for someone seeking a purely laboratory research placement, a general public-policy internship, or a degree programme.

The capstone is a central practical component. Fellows work with a paired member of their cohort, ideally combining different kinds of expertise. The National Academies describes pairings that may bring together scientific, engineering, or medical experience with legal, policy, or regulatory experience. The cohort develops ideas collectively, determines how results can be communicated to agencies, and presents the final projects to the Biotechnology Regulatory Fellowship Advisory Committee, mentors, and agency staff.

The programme may also include topic-specific activities such as workshops, convenings, Congressional hearings, think-tank seminars, and relevant industry conferences. These activities are useful because regulatory work depends on understanding how evidence, institutions, affected communities, companies, and public agencies interact. Applicants should be prepared for a programme that combines reading, discussion, analysis, presentation, and collaborative project work.

Who is eligible

The official criteria are narrow enough to require careful checking but broad enough to welcome several professional backgrounds. Applicants must be U.S. citizens, hold an advanced degree in a relevant field, and have between three and five years of relevant professional experience. For this programme, the National Academies defines an advanced degree as a degree beyond a four-year degree. It also notes that professional experience gained during matriculation can count.

The fellowship is open to early-career professionals with scientific, medical, economic, legal, policy, and other professional backgrounds. Familiarity with regulation and biotechnology is helpful but is not required. The key test is whether the applicant can demonstrate an interest or passion for the regulation of cutting-edge biotechnology products and explain why their prior work gives them a useful perspective.

That flexibility does not mean that any three-to-five-year career history will fit. Relevant experience should connect to the programme’s purpose. Examples might include biotechnology research, clinical or translational work, technology assessment, public-health analysis, legal or regulatory practice, economic analysis, government affairs, science policy, risk assessment, or work that requires interpreting technical evidence for decisions. The applicant must make the connection explicit; reviewers should not have to infer it from job titles.

The public page does not provide a separate list of excluded degrees or a definition of every accepted professional field. If your background is adjacent rather than obviously regulatory, use the application essay to show the bridge. Explain which biotechnology or governance question has attracted your attention, what you have already done to understand it, and what the fellowship would allow you to contribute.

What the day-to-day work may involve

The published structure points to a full-time, collaborative schedule of 37.5 hours per week in Washington, D.C. Plan around the full commitment. This is not described as a part-time award that can be combined with another full-time position, and the stipend is not described as an employee salary.

The work may move among several modes. Seminars will require preparation and active discussion. Horizon scanning will require disciplined reading and comparison of emerging products, technical claims, and potential regulatory gaps. Capstone work will require a pair to choose a manageable question, divide responsibilities, test its reasoning, and present a useful conclusion to an expert audience.

The programme’s stated examples of mentors include current or former personnel from the U.S. Department of Agriculture, the U.S. Environmental Protection Agency, and the U.S. Food and Drug Administration. That does not mean every fellow will be assigned to an agency project or receive a job offer. It does mean applicants should be ready to work across scientific and public-sector perspectives and to make their analysis legible to people who need actionable options rather than an abstract literature review.

Application process and required preparation

The 2027 application cannot be started or submitted now. The National Academies’ official page says the application has closed and asks interested readers to contact the Biotechnology Regulatory Fellowship Office at [email protected]. The application materials below describe the closed cycle, rather than instructions for a currently available submission.

The official application instructions required an online application with applicant profile information, at least three and no more than five research-field keywords or phrases, and an essay of no more than 1,500 words. Applicants registered and logged into the portal, created an application, completed the survey and eligibility pages, and filled in the personal information page. The site required uploaded documents as PDFs, saved as drafts before final submission. Applicants entered two recommenders’ contact details and initiated email requests so the recommenders could upload letters. All components, including both letters, had to arrive by the deadline for the application to be complete and eligible for review. The applicant then used the final submission control and received a confirmation email.

The required curriculum vitae could be no more than ten double-spaced pages in 12-point font with one-inch margins. The requested contents included the applicant’s name and current institutional affiliation; education with degrees, institutions and dates; up to ten significant honors and awards; national or international professional experience; no more than five pages of peer-reviewed publications (with the total publication count optionally stated); and other publications and patents. The instructions said that if a CV exceeded ten pages, only the first ten would be reviewed. Individual citations could be single-spaced.

Two recommendation letters were required. Applicants supplied contact information and initiated requests before submitting. Letter writers needed to know the applicant’s capabilities and professional experience; each letter had to address the applicant’s qualifications relative to the fellowship and stay within two pages. The letters had to be uploaded by the deadline through the application system. Postal or email delivery was not accepted, and the instructions placed responsibility on applicants to verify that both letters were received. The portal emailed confirmations to applicants and writers when uploads succeeded.

Selection was based on expertise in areas relevant to the fellowship, professional achievements, quality of the submitted essay, and recommendations. The public page did not specify a separate essay prompt or scoring weights in the material summarized here. Applicants were responsible for following the instructions visible in the portal and ensuring documents were accurate, legible, complete, unsecured, and correctly formatted. Submitted materials became National Academies property and were not returned; applicants were advised to retain copies. These details are useful to understand the 2027 competition but should not be assumed to govern any future round unless the National Academies republishes them.

How to make the essay persuasive

A strong essay will probably need to do more than express interest in biotechnology. Start with one concrete regulatory problem or class of products that you have reason to understand. The issue might involve a mismatch between product development and existing oversight, uncertainty about evidence standards, the interaction of multiple agencies, or the difficulty of making a technically sound policy usable in practice. Use the problem to establish the question you want to investigate, not to claim that you already have the final answer.

Next, connect the question to your record. Name the project, role, publication, policy exercise, clinical experience, legal matter, or other work that shaped your view. State what you actually did and what you learned. A reviewer can assess “I compared competing risk-assessment approaches and presented the trade-offs to a public-health team” more readily than “I am passionate about innovation and policy.”

Then explain why the fellowship’s method fits. Connect your goals to seminars, horizon scanning, interdisciplinary pairing, mentors, or the capstone presentation. Be specific about the kind of contribution you could make to a pair or cohort and the expertise you hope to develop. Avoid promising a grand solution to all biotechnology regulation. A clearly bounded question with a credible path to useful analysis is stronger than an enormous agenda.

Finally, show the audience for your work. The programme is designed around regulatory options and agency value. Describe who could use the result, what decision it might inform, and what uncertainty would remain. That framing demonstrates that you understand the difference between producing an interesting analysis and producing one that helps institutions act.

Timeline and planning checklist

The official timeline for this closed cycle was:

TimePractical action
June 1, 2026The application opened.
August 31, 2026The application deadline was 11:59 p.m. U.S. Eastern Time; the application is now closed.
September 2–November 30, 2026The program page labels this period “Under review.” Its key-dates section describes review during September–October and status notices in November.
December 1, 2026Recipient announcements are scheduled.
February 1, 2027The fellowship is scheduled to begin in Washington, D.C.
July 31, 2027The six-month fellowship is scheduled to end.

The National Academies does not publish a selection probability. Its page gives both a broad review period and specific milestones: it labels September 2–November 30 as “Under review,” while the key-dates list says applications are reviewed in September–October and applicants are notified in November. The page schedules recipient announcements for December 1. This archive reports those published milestones without implying that every applicant will receive a message on a particular day.

Common mistakes to avoid

The first mistake is treating the award as a conventional salary. The $70,000 is a grant stipend paid during the six-month term, and fellows are not eligible for National Academies employee benefits. Budget for taxes, insurance, housing, relocation, and other costs using your own circumstances rather than assuming an employee package.

The second is ignoring the location and time commitment. A candidate who cannot live in Washington, D.C. and work 37.5 hours per week during the stated dates is not presenting a practical application, regardless of academic strength.

The third is making biotechnology interest too general. The selection process names expertise, achievements, essay quality, and recommendations. Show the connection among those four elements. A technical background without a regulatory question may look unfocused; a policy background without evidence of technical engagement may look thin.

The fourth is proposing a capstone that is too large. The project will be undertaken by a pair during a six-month fellowship that also includes seminars and other activities. Choose a question with identifiable evidence, a plausible method, and a clear audience. A modest project that produces a usable framework is more credible than a sweeping promise to redesign an entire regulatory system.

The fifth is treating an archived call as open. The 2027 application page expressly says that applications have closed. The dates and instructions on this page explain the past cycle; they are not permission to submit late, and they do not predict when another application round will occur. Anyone interested in later opportunities should look for a new announcement from the National Academies rather than reuse the closed deadline or assume that the prior application materials will remain unchanged.

Frequently asked questions

Is the fellowship open to applicants outside the United States?

No. The published eligibility criteria require applicants to be U.S. citizens.

Is this a degree programme?

No. It is a six-month, full-time professional-development fellowship. The public announcement does not describe it as a degree or academic-credit programme.

How much money does a fellow receive?

Each fellow receives a $70,000 stipend in the form of a grant, paid in monthly instalments during the six-month term. The National Academies says fellows are not eligible for its employee benefit programmes.

Do I need a biotechnology or regulatory degree?

Not necessarily. The programme welcomes scientific, medical, economic, legal, policy, and other backgrounds. You do need an advanced degree in a relevant field and three to five years of relevant professional experience, plus a demonstrable interest in regulation of novel biotechnology products.

What were the fellowship dates?

The official page schedules the 2027 fellowship from February 1 through July 31, 2027. The program is full time and in person in Washington, D.C.

What does the selection committee assess?

The official page lists expertise relevant to the fellowship, professional achievements, the quality of the submitted essay, and recommendations.

Can I still apply to the 2027 cycle?

No. The official National Academies page states that the application for 2027 fellowships has closed. It directs questions to [email protected].

Has another cycle been announced?

No later cycle appears on the official program page checked for this update. This page keeps the real 2027 deadline as historical record and does not estimate a future date.

Who should I contact with questions?

The National Academies lists [email protected] for questions about the Biotechnology Regulatory Fellowship.

The National Academies application-process page is the official source for the 2027 cycle’s dates, stipend, eligibility criteria, program description, and selection factors. It states that the 2027 application has closed. The Biotechnology Regulatory Fellowship application site contains the cycle’s more detailed application instructions. The 2027 opportunity required U.S. citizenship, a relevant advanced degree, and three to five years of relevant professional experience; it offered a $70,000 grant stipend for a full-time, six-month fellowship. Its deadline was August 31, 2026 at 11:59 p.m. U.S. Eastern Time. These facts describe the closed cycle only. Contact [email protected] for program questions, and rely on a new official announcement for any future round.

Next step
Check official source